To the full analysis
DENTSPLY SIRONA stock: growth
XRAYDENTSPLY SIRONA reported $3.68B in revenue for fiscal 2025, down 3% on the prior year, up 2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
3.8%
per year from 2006 to 2025, per share 2.4%
Earnings (Annual rate)
no data
Free cash flow (Annual rate)
−3.8%
per year from 2006 to 2025, per share −5.1%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 2.0% | 3.2% | 3.8% |
| Revenue per share | 3.9% | −0.3% | 2.4% |
| Earnings | no data | no data | no data |
| Earnings per share | no data | no data | no data |
| Free cash flow | −28.6% | −13.1% | −3.8% |
| Free cash flow per share | −27.3% | −16.2% | −5.1% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $1.81B | $223.72M | $219.24M |
| 2007 | $2.01B | $259.65M | $321.87M |
| 2008 | $2.19B | $283.87M | $257.06M |
| 2009 | $2.16B | $274.26M | $305.99M |
| 2010 | $2.22B | $265.71M | $316.48M |
| 2011 | $2.54B | $244.52M | $319.22M |
| 2012 | $2.93B | $314.21M | $274.28M |
| 2013 | $2.95B | $313.19M | $316.43M |
| 2014 | $2.92B | $322.85M | $454.63M |
| 2015 | $2.67B | $251.2M | $425.4M |
| 2016 | $3.75B | $429.9M | $437.3M |
| 2017 | $3.99B | −$1.55B | $450.9M |
| 2018 | $3.99B | −$1.01B | $311.8M |
| 2019 | $4.02B | $256M | $509.9M |
| 2020 | $3.34B | −$73M | $562M |
| 2021 | $4.23B | $411M | $515M |
| 2022 | $3.92B | −$950M | $368M |
| 2023 | $3.97B | −$132M | $228M |
| 2024 | $3.79B | −$910M | $281M |
| 2025 | $3.68B | −$598M | $104M |
Revenue by segment
How DENTSPLY SIRONA Inc. makes its money and how that has shifted. Names are as the company reports them.
- Technologies And Equipment59%
- Consumables41%
Figures as a table
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Share 2022 | |
|---|---|---|---|---|---|---|---|
| Technologies And Equipment | $2.2B | $2.14B | $2.28B | $1.96B | $2.52B | $2.32B | 59.1% |
| Consumables | $1.79B | $1.85B | $1.75B | $1.38B | $1.73B | $1.6B | 40.9% |
| Total revenue | $3.99B | $3.99B | $4.02B | $3.34B | $4.23B | $3.92B | 100% |
Revenue by region
Where DENTSPLY SIRONA Inc. generates its revenue.
- Europe43%
- United States32%
- Other25%
“Other” combines smaller regions with revenue the company does not assign to a region.
Figures as a table
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|---|---|
| Europe | $1.61B | $1.39B | $1.69B | $1.56B | $1.55B | $1.52B | $1.58B | 42.8% |
| United States | $1.37B | $1.11B | $1.5B | $1.39B | $1.44B | $1.35B | $1.18B | 32.1% |
| Other | $1.04B | $843M | $1.05B | $971M | $978M | $927M | $922M | 25.1% |
| Total revenue | $4.02B | $3.34B | $4.23B | $3.92B | $3.97B | $3.79B | $3.68B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 30 Nov 2022)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.